Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2385]

EBCC 8 Follow-Up: Benefit of screening for breast cancer with mammography

EBCC 8 Follow-Up: Benefit of screening for breast cancer with mammography

EBCC 8: Overweight and obese women at greater risk of breast cancer recurrence even after chemotherapy dose adjustment

EBCC 8: Overweight and obese women at greater risk of breast cancer recurrence even after chemotherapy dose...

EBCC 8: Everolimus plus exemestane improves bone health in post-menopausal women with advanced breast cancer

EBCC 8: Everolimus plus exemestane improves bone health in post-menopausal women with advanced breast cancer

Understanding individual genetic variation can help predict chemotherapy side effects

Understanding individual genetic variation can help predict chemotherapy side effects

Study shows cobalt-chromium everolimus-eluting stents have lower short-term and long-term thrombosis rates

Study shows cobalt-chromium everolimus-eluting stents have lower short-term and long-term thrombosis rates

Men who have sex with men at high risk for pre-cancerous anal lesions

Men who have sex with men at high risk for pre-cancerous anal lesions

Scientists identify new mechanism of prostate cancer cell metabolism

Scientists identify new mechanism of prostate cancer cell metabolism

EBCC 8: New genomic test spares patients chemotherapy with no adverse effect on survival

EBCC 8: New genomic test spares patients chemotherapy with no adverse effect on survival

EBCC 8: Radiotherapy for DCIS still protects against recurrence after fifteen years

EBCC 8: Radiotherapy for DCIS still protects against recurrence after fifteen years

To promote lasting impact, cancer drugs should force dying cells to alert immune response

To promote lasting impact, cancer drugs should force dying cells to alert immune response

More from ecancer